BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pisetsky DS, Lipsky PE. New insights into the role of antinuclear antibodies in systemic lupus erythematosus. Nat Rev Rheumatol 2020;16:565-79. [PMID: 32884126 DOI: 10.1038/s41584-020-0480-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Yu C, Liang D, Yang C, Zhao B, Dong Q, Wu A, Li L, Zang H. Research progress and the application of near-infrared spectroscopy in protein structure and molecular interaction analysis. Vibrational Spectroscopy 2022;121:103390. [DOI: 10.1016/j.vibspec.2022.103390] [Reference Citation Analysis]
2 Aringer M, Schneider M. [Systemic lupus erythematosus]. Internist (Berl) 2021;62:385-96. [PMID: 33512549 DOI: 10.1007/s00108-021-00948-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kim H, Lee JW, Han G, Kim K, Yang Y, Kim SH. Extracellular Vesicles as Potential Theranostic Platforms for Skin Diseases and Aging. Pharmaceutics 2021;13:760. [PMID: 34065468 DOI: 10.3390/pharmaceutics13050760] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Herbert A, Karapetyan S, Poptsova M, Vasquez KM, Vicens Q, Vögeli B. Special Issue: A, B and Z: The Structure, Function and Genetics of Z-DNA and Z-RNA. Int J Mol Sci 2021;22:7686. [PMID: 34299306 DOI: 10.3390/ijms22147686] [Reference Citation Analysis]
5 Li M, Liang J, Pan W, Liu L, Wu M, Ding F, Hu H, Ding X, Wei H, Zou Y, Qian X, Wang M, Wu J, Tao J, Tan J, Da Z, Zhang M, Li J, Feng X, Wen L, Zhang H, Sun L. Predictors of improvement in disease activity in first hospitalized patients with systemic lupus erythematosus: a multicenter retrospective study of a Chinese cohort. Clin Rheumatol 2022. [PMID: 35849245 DOI: 10.1007/s10067-022-06289-7] [Reference Citation Analysis]
6 Wang EY, Dai Y, Rosen CE, Schmitt MM, Dong MX, Ferré EMN, Liu F, Yang Y, González-Hernández JA, Meffre E, Hinchcliff M, Koumpouras F, Lionakis MS, Ring AM. High-throughput identification of autoantibodies that target the human exoproteome. Cell Rep Methods 2022;2:100172. [PMID: 35360706 DOI: 10.1016/j.crmeth.2022.100172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Nakai T, Fukui S, Ikeda Y, Suda M, Tamaki H, Okada M. Glucocorticoid discontinuation in patients with SLE with prior severe organ involvement: a single-center retrospective analysis. Lupus Sci Med 2022;9:e000682. [PMID: 35654482 DOI: 10.1136/lupus-2022-000682] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Endres D, Pollak TA, Bechter K, Denzel D, Pitsch K, Nickel K, Runge K, Pankratz B, Klatzmann D, Tamouza R, Mallet L, Leboyer M, Prüss H, Voderholzer U, Cunningham JL, Domschke K, Tebartz van Elst L, Schiele MA; ECNP Network Immuno-NeuroPsychiatry. Immunological causes of obsessive-compulsive disorder: is it time for the concept of an "autoimmune OCD" subtype? Transl Psychiatry 2022;12:5. [PMID: 35013105 DOI: 10.1038/s41398-021-01700-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
9 Ortega A, Martinez-Arroyo O, Forner MJ, Cortes R. Exosomes as Drug Delivery Systems: Endogenous Nanovehicles for Treatment of Systemic Lupus Erythematosus. Pharmaceutics 2020;13:E3. [PMID: 33374908 DOI: 10.3390/pharmaceutics13010003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
10 Granito A, Muratori L, Tovoli F, Muratori P. Diagnostic role of anti-dsDNA antibodies: do not forget autoimmune hepatitis. Nat Rev Rheumatol 2021;17:244. [PMID: 33462415 DOI: 10.1038/s41584-021-00573-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Shen WY, Luo C, Hurtado PR, Liu XJ, Luo RY, Li H, Hu ZL, Xu JM, Coulson EJ, Zhao M, Zhou XF, Dai RP. Up-regulation of proBDNF/p75NTR signaling in antibody-secreting cells drives systemic lupus erythematosus. Sci Adv 2022;8:eabj2797. [PMID: 35044824 DOI: 10.1126/sciadv.abj2797] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zheng Z, Chang L, Li J, Wu Y, Chen G, Zou L. Insights Gained and Future Outlook From scRNAseq Studies in Autoimmune Rheumatic Diseases. Front Immunol 2022;13:849050. [PMID: 35251048 DOI: 10.3389/fimmu.2022.849050] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Bhamidipati K, Silberstein JL, Chaichian Y, Baker MC, Lanz TV, Zia A, Rasheed YS, Cochran JR, Robinson WH. CD52 Is Elevated on B cells of SLE Patients and Regulates B Cell Function. Front Immunol 2020;11:626820. [PMID: 33658999 DOI: 10.3389/fimmu.2020.626820] [Reference Citation Analysis]
14 Bisoendial R, Lubberts E, Caruso C. A Mechanistic Insight into the Pathogenic Role of Interleukin 17A in Systemic Autoimmune Diseases. Mediators of Inflammation 2022;2022:1-14. [DOI: 10.1155/2022/6600264] [Reference Citation Analysis]
15 Choi MY, Clarke AE, Urowitz M, Hanly J, St-Pierre Y, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Wallace DJ, Isenberg D, Rahman A, Merrill JT, Fortin PR, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Ramsey-Goldman R, Manzi S, Jönsen A, Alarcón GS, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Lim S, Inanc M, Kalunian K, Jacobsen S, Peschken C, Kamen DL, Askanase A, Buyon JP, Costenbader KH, Fritzler MJ. Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort. Ann Rheum Dis 2022:annrheumdis-2022-222168. [PMID: 35338033 DOI: 10.1136/annrheumdis-2022-222168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Yavuz S, Lipsky PE. Current Status of the Evaluation and Management of Lupus Patients and Future Prospects. Front Med (Lausanne) 2021;8:682544. [PMID: 34124113 DOI: 10.3389/fmed.2021.682544] [Reference Citation Analysis]
17 Karahan S, Emre Ş, Hörmet-Öz HT. Anti - Dense Fıne Speckled (DFS) Antibody: its staınıng pattern in indirect immunofluorescence and its clinical relevance. Rom J Intern Med 2021. [PMID: 34333888 DOI: 10.2478/rjim-2021-0029] [Reference Citation Analysis]
18 Owen KA, Grammer AC, Lipsky PE. Deconvoluting the heterogeneity of SLE: The contribution of ancestry. J Allergy Clin Immunol 2021:S0091-6749(21)01762-0. [PMID: 34857396 DOI: 10.1016/j.jaci.2021.11.005] [Reference Citation Analysis]
19 Elsayed SA, Kamaly HM, Esmail MA. Co-positivity of anti-dsDNA, anti-nucleosome, and anti-smith autoantibodies as serological biomarkers for disease activity in systemic lupus erythematosus. Egypt Rheumatol Rehabil 2022;49. [DOI: 10.1186/s43166-021-00110-0] [Reference Citation Analysis]
20 Pisetsky DS, Garza Reyna A, Belina ME, Spencer DM. The Interaction of Anti-DNA Antibodies with DNA: Evidence for Unconventional Binding Mechanisms. IJMS 2022;23:5227. [DOI: 10.3390/ijms23095227] [Reference Citation Analysis]
21 Lee DSW, Rojas OL, Gommerman JL. B cell depletion therapies in autoimmune disease: advances and mechanistic insights. Nat Rev Drug Discov 2021;20:179-99. [PMID: 33324003 DOI: 10.1038/s41573-020-00092-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 9.5] [Reference Citation Analysis]
22 Zhu H, Kong B, Nie M, Zhao C, Liu R, Xie Y, Zhao Y, Sun L. ECM-inspired peptide dendrimer microgels with human MSCs encapsulation for systemic lupus erythematosus treatment. Nano Today 2022;43:101454. [DOI: 10.1016/j.nantod.2022.101454] [Reference Citation Analysis]
23 Ntouros PA, Vlachogiannis NI, Pappa M, Nezos A, Mavragani CP, Tektonidou MG, Souliotis VL, Sfikakis PP. Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus. Clin Immunol 2021;229:108765. [PMID: 34089859 DOI: 10.1016/j.clim.2021.108765] [Reference Citation Analysis]
24 Moeller MJ, Kramann R, Lammers T, Hoppe B, Latz E, Ludwig-Portugall I, Boor P, Floege J, Kurts C, Weiskirchen R, Ostendorf T. New Aspects of Kidney Fibrosis-From Mechanisms of Injury to Modulation of Disease. Front Med (Lausanne) 2021;8:814497. [PMID: 35096904 DOI: 10.3389/fmed.2021.814497] [Reference Citation Analysis]
25 Aringer M, Schneider M. [Systemic lupus erythematosus]. Hautarzt 2021;72:337-48. [PMID: 33740079 DOI: 10.1007/s00105-021-04794-5] [Reference Citation Analysis]
26 Gomes C, Zuniga M, Crotty KA, Qian K, Tovar NC, Lin LH, Argyropoulos KV, Clancy R, Izmirly P, Buyon J, Lee DC, Yasnot-Acosta MF, Li H, Cotzia P, Rodriguez A. Autoimmune anti-DNA and anti-phosphatidylserine antibodies predict development of severe COVID-19. Life Sci Alliance 2021;4:e202101180. [PMID: 34504035 DOI: 10.26508/lsa.202101180] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Hong J, Zhang M, He Y, Jin Y, He Q, Zhang Y, Shi X, Tian W, Wen C, Chen J. Qinghao-Biejia Herb Pair Alleviates Pristane-Induced Lupus-Like Disease and Associated Renal and Aortic Lesions in ApoE−/− Mice. Front Pharmacol 2022;13:897669. [DOI: 10.3389/fphar.2022.897669] [Reference Citation Analysis]
28 [DOI: 10.1101/2021.01.04.20249054] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Zhao L, Hu X, Xiao F, Zhang X, Zhao L, Wang M. Mitochondrial impairment and repair in the pathogenesis of systemic lupus erythematosus. Front Immunol 2022;13:929520. [DOI: 10.3389/fimmu.2022.929520] [Reference Citation Analysis]
30 Hubbard EL, Pisetsky DS, Lipsky PE. Anti-RNP antibodies are associated with the interferon gene signature but not decreased complement levels in SLE. Ann Rheum Dis 2022:annrheumdis-2021-221662. [PMID: 35115332 DOI: 10.1136/annrheumdis-2021-221662] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Yu H, Nagafuchi Y, Fujio K. Clinical and Immunological Biomarkers for Systemic Lupus Erythematosus. Biomolecules 2021;11:928. [PMID: 34206696 DOI: 10.3390/biom11070928] [Reference Citation Analysis]
32 Bou-Nader C, Bothra A, Garboczi DN, Leppla SH, Zhang J. Structural basis of R-loop recognition by the S9.6 monoclonal antibody. Nat Commun 2022;13:1641. [PMID: 35347133 DOI: 10.1038/s41467-022-29187-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
33 You R, He X, Zeng Z, Zhan Y, Xiao Y, Xiao R. Pyroptosis and Its Role in Autoimmune Disease: A Potential Therapeutic Target. Front Immunol 2022;13:841732. [PMID: 35693810 DOI: 10.3389/fimmu.2022.841732] [Reference Citation Analysis]
34 González-Serna D, Villanueva-Martin G, Acosta-Herrera M, Márquez A, Martín J. Approaching Shared Pathophysiology in Immune-Mediated Diseases through Functional Genomics. Genes (Basel) 2020;11:E1482. [PMID: 33317201 DOI: 10.3390/genes11121482] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Pisetsky DS, Lipsky PE. Reply to: Diagnostic role of anti-dsDNA antibodies: do not forget autoimmune hepatitis. Nat Rev Rheumatol 2021;17:245. [PMID: 33462416 DOI: 10.1038/s41584-021-00574-6] [Reference Citation Analysis]
36 Amo L, Kole HK, Scott B, Qi CF, Wu J, Bolland S. CCL17-producing cDC2s are essential in end-stage lupus nephritis and averted by a parasitic infection. J Clin Invest 2021;131:148000. [PMID: 34060489 DOI: 10.1172/JCI148000] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Karlsson J, Wetterö J, Weiner M, Rönnelid J, Fernandez-Botran R, Sjöwall C. Associations of C-reactive protein isoforms with systemic lupus erythematosus phenotypes and disease activity. Arthritis Res Ther 2022;24:139. [PMID: 35690780 DOI: 10.1186/s13075-022-02831-9] [Reference Citation Analysis]
38 Jiménez-Zarazúa O, Vélez-Ramírez LN, Ramírez-Casillas CA, Mondragón JD. Pulmonary thromboembolism and alveolar hemorrhage as initial manifestations of systemic lupus erythematosus. Lupus 2022;:9612033211066481. [PMID: 35042383 DOI: 10.1177/09612033211066481] [Reference Citation Analysis]
39 Alexander RV, Rey DS, Conklin J, Domingues V, Ahmed M, Qureshi J, Weinstein A. A multianalyte assay panel with cell-bound complement activation products demonstrates clinical utility in systemic lupus erythematosus. Lupus Sci Med 2021;8:e000528. [PMID: 34253650 DOI: 10.1136/lupus-2021-000528] [Reference Citation Analysis]
40 Sim TM, Ong SJ, Mak A, Tay SH. Type I Interferons in Systemic Lupus Erythematosus: A Journey from Bench to Bedside. Int J Mol Sci 2022;23:2505. [PMID: 35269647 DOI: 10.3390/ijms23052505] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Xu C, Wu Y, Liu N. Osteopontin in autoimmune disorders: current knowledge and future perspective. Inflammopharmacology 2022. [PMID: 35235108 DOI: 10.1007/s10787-022-00932-0] [Reference Citation Analysis]
42 Huang X, Zhang Q, Zhang H, Lu Q. A Contemporary Update on the Diagnosis of Systemic Lupus Erythematosus. Clinic Rev Allerg Immunol. [DOI: 10.1007/s12016-021-08917-7] [Reference Citation Analysis]
43 Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, Li S, Hong S, Zhang R, Xie J, Kornilov SA, Scherler K, Pavlovitch-Bedzyk AJ, Dong S, Lausted C, Lee I, Fallen S, Dai CL, Baloni P, Smith B, Duvvuri VR, Anderson KG, Li J, Yang F, Duncombe CJ, McCulloch DJ, Rostomily C, Troisch P, Zhou J, Mackay S, DeGottardi Q, May DH, Taniguchi R, Gittelman RM, Klinger M, Snyder TM, Roper R, Wojciechowska G, Murray K, Edmark R, Evans S, Jones L, Zhou Y, Rowen L, Liu R, Chour W, Algren HA, Berrington WR, Wallick JA, Cochran RA, Micikas ME, Wrin T, Petropoulos CJ, Cole HR, Fischer TD, Wei W, Hoon DSB, Price ND, Subramanian N, Hill JA, Hadlock J, Magis AT, Ribas A, Lanier LL, Boyd SD, Bluestone JA, Chu H, Hood L, Gottardo R, Greenberg PD, Davis MM, Goldman JD, Heath JR; ISB-Swedish COVID-19 Biobanking Unit. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 2022;185:881-895.e20. [PMID: 35216672 DOI: 10.1016/j.cell.2022.01.014] [Cited by in Crossref: 45] [Cited by in F6Publishing: 17] [Article Influence: 45.0] [Reference Citation Analysis]
44 Al-Mughales JA. Anti-Nuclear Antibodies Patterns in Patients With Systemic Lupus Erythematosus and Their Correlation With Other Diagnostic Immunological Parameters. Front Immunol 2022;13:850759. [PMID: 35359932 DOI: 10.3389/fimmu.2022.850759] [Reference Citation Analysis]
45 Chalayer E, Gramont B, Zekre F, Goguyer-Deschaumes R, Waeckel L, Grange L, Paul S, Chung AW, Killian M. Fc receptors gone wrong: A comprehensive review of their roles in autoimmune and inflammatory diseases. Autoimmun Rev 2021;21:103016. [PMID: 34915182 DOI: 10.1016/j.autrev.2021.103016] [Reference Citation Analysis]
46 Khan S, Anvekar P, Lohana P, Sheeraz Alam M, Ali SR. Fetal Congenital Heart Block Associated With Maternal Primary Systemic Lupus Erythematosus and Sjogren's Syndrome. Cureus 2021;13:e18036. [PMID: 34671524 DOI: 10.7759/cureus.18036] [Reference Citation Analysis]
47 Pahan S, Pahan K. Can cinnamon spice down autoimmune diseases? J Clin Exp Immunol 2020;5:252-8. [PMID: 33294884 DOI: 10.33140/jcei.05.06.01] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]